Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,127,897
-
Total 13F shares
-
57,634,977
-
Share change
-
+20,754,224
-
Total reported value
-
$810,618,371
-
Put/Call ratio
-
12%
-
Price per share
-
$14.08
-
Number of holders
-
102
-
Value change
-
+$319,828,537
-
Number of buys
-
70
-
Number of sells
-
37
Institutional Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q1 2024
As of 31 Mar 2024,
Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,634,977 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., FMR LLC, VR Adviser, LLC, BlackRock Inc., Fairmount Funds Management LLC, VANGUARD GROUP INC, Vivo Capital, LLC, and STATE STREET CORP.
This page lists
102
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.